Ryman Healthcare

Last updated

Ryman Healthcare Limited
Company type Public
NZX: RYM
IndustryAged care
Founded1984 founded, 1999 IPO
FounderJohn Ryder, Kevin Hickman
Headquarters
Christchurch
,
New Zealand
Areas served
NZ, Australia
Key people
CEO – Richard Umbers, CFO – David Bennett,
Acting chair – Claire Higgins
ProductsRetirement villages and aged care
OwnerPublic listing company (NZX)
Number of employees
5000+
Website www.rymanhealthcare.co.nz

Ryman Healthcare Limited is a New Zealand retirement village and rest home operator. It is listed on the New Zealand Stock Exchange and is one of the largest companies listed on the NZX 50 Index. [1] [2]

Contents

Ryman Healthcare has 38 operational villages across New Zealand and seven in Melbourne, and is developing another six villages in Victoria, Australia. Its name is a portmanteau of its two founders, John Ryder and Kevin Hickman, who founded the company in 1984. [3]

As at May 2022, Ryman Healthcare has a market capitalisation of over $4.4 Billion NZD. [4]

Ryman's business model is a mixture of property development and healthcare services. It operates on a "deferred management fees" model where the village resident pays for a lifetime occupancy use of their apartment or unit, and upon moving out, the resident or their estate receives a lesser sum back for their unit, capped at 20% deducted if over a five-year period.

Ryman Healthcare villages offer a blend of different retirement living options at their villages, which are usually large enough to support a mini-hospital for residents and a secure dementia wing. Ryman describe this as a "continuum of care" where residents can remain in the Ryman village of choice, whether it is for independent retirement living, rest home care, dementia or hospital care. [5] All villages are named after Kiwi or Australian "trailblazers" [6]

Ryman expanded into Australia in 2012, buying a site for development in Wheelers Hill, in eastern Melbourne, Victoria. [7] Ryman has since purchased another eight sites for development at Brandon Park, Burwood East, Coburg, Mt Eliza, Mt Martha, Aberfeldie, Ocean Grove and Geelong. [8] [9]

Company performance

Ryman Healthcare has demonstrated significant profit and share price performance since its inception. For the last five years, it has managed earnings growth of over 15% per annum. [10] Ryman has delivered 15 years of consecutive record earnings results since 2002. [11] Ryman employs over 6700 people, including in house development teams, builders and tradespeople, nursing and caregivers, cooks, cleaners, sales and support staff. Ryman villages are home to more than 13,200 residents.

Awards

Ryman Healthcare have won a number of awards for business and healthcare, including:

The Ryman Prize

In 2015 Ryman Healthcare announced it was supporting the launch of the Ryman Prize. [17]

The Ryman Prize [18] is an annual $250,000 NZD for the best idea, innovation or advance in the world that enhances quality of life for older people. It is a philanthropic initiative administered by The Ryman Foundation. Hollows Foundation founding director Gabi Hollows won the inaugural Ryman Prize [19] for her decades of work to restore the sight of more than 1 million people with preventable blindness.

Alzheimer's Disease researcher Professor Henry Brodaty won the 2016 prize. Professor Brodaty, who lives in Sydney, is Scientia Professor of Ageing and Mental Health, the founding Director of the Dementia Collaborative Research Centre and Co-Director of CHeBA, the Centre for Healthy Brain Ageing at the University of New South Wales. [20]

The 2017 Ryman Prize went to Professor Peter St George-Hyslop. Professor St George-Hyslop is a medical scientist, neurologist and molecular geneticist who is known for his research into neurodegenerative diseases. He has identified a number of key genes that are responsible for nerve cell degeneration and early-onset forms of Alzheimer's disease. He splits his time between the University of Cambridge and the University of Toronto where he has research labs. [21] [ circular reference ] [22] [23]

Professor Takanori Shibata was awarded the 2018 Ryman Prize in recognition of his more than 25 years of ground-breaking research into new technology to help older people.

Professor Shibata, an artificial intelligence (AI) and robotics pioneer, was presented with the prize by the Right Honourable Jacinda Ardern, Prime Minister of New Zealand.

The 2019 Ryman Prize was awarded to Dr Michael Fehlings, a Canadian neurosurgeon, for his pioneering research into degenerative cervical myelopathy (DCM), a spinal disorder that affects older people. [24]

The 2020 Ryman Prize went to Dr. Miia Kivipelto of Finland, for her work on cognitive impairment, Alzheimer's disease, and dementia.

The 2021 Ryman prize was awarded to Dr. Kenneth Rockwood [25] of Dalhousie University in Halifax, Nova Scotia, for his work on a geriatric Frailty index, done jointly with Dr. Arnold Mitnitski, also of Dalhousie University.

The 2022 Ryman Prize was awarded to Professor Perminder Sachdev, neuropsychiatrist and Scientia Professor at the University of New South Wales in Sydney for his more than 30 years of research into the causes and treatment of psychiatric disorders including dementia.

Related Research Articles

<span class="mw-page-title-main">Infratil</span> New Zealand investment company

Infratil Limited is a New Zealand-based infrastructure investment company. It owns renewable energy, digital infrastructure, airports, and healthcare assets with operations in New Zealand, Australia, Asia, the US and Europe. Infratil was founded by the late Lloyd Morrison, a Wellington-based merchant banker. Morrison's company, H. R. L. Morrison & Co, is responsible for Infratil's management and administration.

<span class="mw-page-title-main">Lloyd Morrison</span>

Hugh Richmond Lloyd Morrison was a Wellington, New Zealand-based investment banker and entrepreneur. He founded H.R.L. Morrison & Co in 1988, and Morrison & Co launched the infrastructure company Infratil in 1994.

Green Cross Health is a provider of primary health care services around New Zealand, including pharmacies and medical clinics. It is based in Ellerslie, Auckland.

<span class="mw-page-title-main">SLI Systems</span>

SLI Systems provided cloud-based search tools for online retailers under a "software as a service" (SaaS) model. It was a public company listed on the New Zealand stock exchange.

Peter Henry St George-Hyslop, OC, FRS, FRSC, FRCPC, is a British and Canadian medical scientist, neurologist and molecular geneticist who is known for his research into neurodegenerative diseases. St George-Hyslop is one of the most cited authors in the field of Alzheimer's disease research. He has identified a number of key genes that are responsible for nerve cell degeneration and early-onset forms of Alzheimer's disease. These include the discovery of the presenilins, Nicastrin, and SORL1 genes. Presenilin mutations are the most common cause of familial Alzheimer's disease. St George-Hyslop also co-led the discovery of the gene for the amyloid precursor protein.

Perminder Sachdev is an Indian neuropsychiatrist based in Australia. He is a professor of neuropsychiatry at the University of New South Wales (UNSW), co-director of the UNSW Centre for Healthy Brain Aging, and clinical director of the Neuropsychiatric Institute at the Prince of Wales Hospital, Sydney. He is considered a trailblazer in the field of neuropsychiatry. Sachdev's research interests include ageing, vascular cognitive disorders such as vascular dementia, and psychiatric disorders.

Jean Mary Sandel was a New Zealand surgeon, and the first New Zealand woman to be made a Fellow of the Royal College of Surgeons in 1947.

Snakk Media is a mobile advertising company, established in 2010 by Derek Handley, Geoffrey Handley, and Andrew Jacobs. Snakk Media is headquartered in Auckland, New Zealand.

<span class="mw-page-title-main">GeoOp</span> Publicly listed New Zealand technology company

Geo Limited is a publicly listed company in New Zealand.

<span class="mw-page-title-main">My Food Bag</span> New Zealand meal kit home delivery service

My Food Bag is a New Zealand meal-kit home-delivery service providing customers with ingredients and recipes to cook meals. The company is publicly traded and was floated on the NZX and ASX on 5 March 2021.

Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the New Zealand NZX main board stock exchange and is included in the NZX 50 Index.

Summerset Holdings Limited is a New Zealand retirement village and aged care service provider. They are listed on the NZX and are part of the NZX 50 index, with a market capitalisation of nearly $2.3 billion NZD.

Metlifecare is one of New Zealand's largest retirement village providers. They currently own and operate 43 retirement villages throughout the North Island of New Zealand.

<span class="mw-page-title-main">Diligent Corporation</span> American technology company

Diligent Corporation, known as Diligent, is a software as a service company that enables groups to share and collaborate information for board meetings. Headquartered in New York City, and incorporated in Delaware, the company has offices in Galway, Ireland; London, UK; Washington, D.C.; Munich, Germany; Budapest, Hungary; Hong Kong; Bangalore, India; Sydney and Vancouver.

The Prime Minister's Science Prizes are awarded yearly by the Prime Minister of New Zealand. They were first awarded in 2009 in order to raise the profile and prestige of science among New Zealanders. The 2019 awards were presented in early 2020.

Wendy Fleming is a New Zealand expert on Alzheimer’s disease and dementia. In 2018 she was made a Companion of the Royal Society Te Apārangi in recognition of her contributions to the promotion of dementia research in New Zealand.

<span class="mw-page-title-main">Miia Kivipelto</span> Finnish neurologist (born 1973)

Miia K. Kivipelto is a Finnish neuroscientist and professor at the University of Eastern Finland and Karolinska Institute in Stockholm. Her research focuses on dementia and Alzheimer's disease.

<span class="mw-page-title-main">Dementia and Alzheimer's disease in Australia</span> Major health issue in Australia

Dementia and Alzheimer's disease in Australia is a major health issue. Alzheimer's disease is the most common type of dementia in Australia. Dementia is an ever-increasing challenge as the population ages and life expectancy increases. As a consequence, there is an expected increase in the number of people with dementia, posing countless challenges to carers and the health and aged care systems. In 2018, an estimated 376,000 people had dementia; this number is expected to increase to 550,000 by 2030 and triple to 900,000 by 2050. The dementia death rate is increasing, resulting in the shift from fourth to second leading cause of death from 2006 to 2015. It is expected to become the leading cause of death over the next number of years. In 2011, it was the fourth leading cause of disease burden and third leading cause of disability burden. This is expected to remain the same until at least 2020.

Constantine G. Lyketsos is the Elizabeth Plank Althouse Professor in Alzheimer's Disease Research in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University, Baltimore, Maryland, United States. He is the founding director of the Richman Family Precision Medicine Center of Excellence in Alzheimer's Disease, and an associate director of the Johns Hopkins Alzheimer's Disease Research Center (ADRC).

Charles Fleming Retirement Village is a retirement village in Waikanae, New Zealand. Opened in 2013 and named after Sir Charles Fleming, it houses 140 beds with a resident capacity of over 400. It was built by Ryman Healthcare with a construction cost of $100 million. It includes a dementia facility, independent units and townhouses. The main block of apartments is three storeys high.

References

  1. ↑ "Living & Care Options". Ryman Healthcare. Retrieved 20 November 2012.
  2. ↑ "NZX Main Board | RYM". New Zealand Stock Exchange. Retrieved 20 November 2012.
  3. ↑ "Our History". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  4. ↑ "Creating Shareholder Value". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  5. ↑ "Continuum of Care – Resthomes, Hospital Facilities, Elderly Community | Ryman Healthcare, New Zealand". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  6. ↑ Healthcare, Ryman. "William Sanders Retirement Village | Devonport | Auckland". www.rymanhealthcare.co.nz. Retrieved 17 February 2024.
  7. ↑ Steeman, Marta. "Ryman Healthcare cautious Aussie debut". Fairfax New Zealand Limited. Retrieved 20 November 2012.
  8. ↑ "Ryman Healthcare expands into Geelong - NZX, New Zealand's Exchange". www.nzx.com. Retrieved 21 February 2023.
  9. ↑ "Ryman to spend $100m on second Melbourne village". NZ Herald. Retrieved 21 February 2023.
  10. ↑ "Share Performance". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  11. ↑ "Thirteen Years of Record Results". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  12. ↑ "Ryman Healthcare achieves top 10 world ranking". 15 August 2017 – via www.nzherald.co.nz.
  13. ↑ "How Top Value Creators Outpace the Market—for Decades". www.bcg.com.
  14. ↑ "Ryman managing director wins Deloitte Top 200 award". www.rymanhealthcare.co.nz. Retrieved 31 December 2015.
  15. ↑ "Trusted Brands New Zealand Ryman Healthcare Showcase". www.trustedbrands.co.nz. Retrieved 31 December 2015.
  16. ↑ "Workbase Top 200 award Ryman healthcare". workbase.org.nz. Retrieved 31 December 2015.
  17. ↑ "Prime Minister launches US$150,000 international prize". Archived from the original on 27 February 2018. Retrieved 1 October 2017.
  18. ↑ Healthcare, Ryman. "The Ryman Prize - Winners". Ryman Healthcare. Retrieved 18 November 2022.
  19. ↑ "Gabi Hollows 'honoured' to be awarded Ryman prize" – via TVNZ.
  20. ↑ Healthcare, Ryman. "The Ryman Prize | Ryman Healthcare". www.rymanhealthcare.co.nz.
  21. ↑ Peter St George-Hyslop
  22. ↑ "Top Alzheimer's researcher receives Ryman Prize | INsite Magazine". Archived from the original on 2 October 2017. Retrieved 1 October 2017.
  23. ↑ "Alzheimer's will be cured, but world expert can't say when". Stuff.
  24. ↑ "Canadian neurosurgeon wins Ryman Prize".
  25. ↑ "Halifax physician Ken Rockwood wins international award for dementia work - Halifax". Global News. 15 December 2021. Retrieved 18 November 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.